-
Health and WellnessA clinical trial for a HIV vaccine has been an overwhelming success
The first phase of the trial was 97 percent successful in “stimulating production of rare immune cells” that are resistant to HIV.
The first phase of the trial was 97 percent successful in “stimulating production of rare immune cells” that are resistant to HIV.
